OMass Therapeutics

Omass

Oxford, United Kingdom · $130.5M raised

Headquarters
Oxford
Business Model
B2B
Website
omass.com
Total Funding
$130.5M
Last Round
$12.5M Extension RoundMay 2023
Rounds
3

About

OMass Therapeutics identifies new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry, and custom chemistry. The company focuses on target ecosystems such as membrane proteins and intracellular complexes, distilling biology to physical interactions within a native ecosystem. It is advancing a pipeline of small molecule therapeutics for orphan diseases and immunological conditions, targeting solute carriers, inflammasome complexes, and GPCRs.

Summary

OMass Therapeutics is a Biotech company based in Oxford, United Kingdom. It has raised $130.5M in total across 3 rounds, most recently a $12.5M Extension Round round in May 2023. Investors include British Patient Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundMay 2023
$12.5M

Sign up to see all 3 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OMass Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/omass-therapeutics"><img src="https://indexed.vc/api/badge/company/omass-therapeutics" alt="OMass Therapeutics on Indexed.vc" width="260" height="76" /></a>